Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions ...

A growing body of research is finding a robust link between diet and sleep quality. But it’s not just the usual suspects like ...

Older adults ... sleep apnea specific antidepressants to treat insomnia dopamine agents for restless leg syndrome and periodic limb movement disorder iron replacement therapy for restless leg ...

Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...

For individuals with mmOSA, CRP levels were associated with hypertension risk and insulin resistance among those aged less than 60 years.

5, 2024 — Sleep is ... depression symptoms, directly and indirectly, by improving mood and alleviating insomnia throughout ... Sleep Apnea Contributes to Dementia in Older Adults, Especially ...

As cases of HMPV virus rise in China, experts are exploring potential links to autoimmune encephalitis. Recent findings in ...

A recent study shows getting walking more may help prevent depressive symptoms. Tracking your steps may help you stay ...

Sleep apnea, a condition that disrupts breathing during sleep, affects millions of people worldwide, especially adults over ...